Genetic susceptibility to malignant neoplasm of ovary
ICD-10 Z15.02 is a billable code used to indicate a diagnosis of genetic susceptibility to malignant neoplasm of ovary.
Z15.02 indicates a genetic predisposition to ovarian cancer, often linked to mutations in genes such as BRCA1 and BRCA2. This code is crucial for identifying patients who may benefit from enhanced screening and preventive measures due to their genetic background. Social determinants of health, such as access to genetic counseling, socioeconomic status, and education about cancer risks, significantly influence health outcomes for these patients. Preventive care may include regular screenings, lifestyle modifications, and discussions about prophylactic surgeries. Screening protocols should be tailored to the individual's risk factors, and aftercare may involve ongoing monitoring and support for those with a family history of ovarian cancer. Accurate coding of Z15.02 ensures that healthcare providers can implement appropriate preventive strategies and allocate resources effectively.
Document family history, genetic testing results, and preventive care plans.
Routine checkups for patients with a family history of ovarian cancer, referrals for genetic counseling.
Consider social determinants such as access to care and patient education on genetic risks.
Population health data on genetic predisposition and cancer incidence.
Community outreach programs for genetic screening and education.
Focus on health disparities and access to genetic counseling services.
Used for patients with Z15.02 to confirm genetic predisposition.
Document the reason for testing and results.
Primary care providers should coordinate with genetic counselors.
Documentation must include the patient's family history of ovarian cancer, results of any genetic testing, and a plan for preventive care. This ensures that the code is used appropriately and supports the need for enhanced screening.
